Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD81 | P60033 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21082716 | 1.00 | CD81 (0.34) | CD81ALDH1A1CA2PPARG | |
| SCHEMBL15475742 | 1.00 | CD81 (0.34) | CD81ALDH1A1CA2PPARG | |
| SCHEMBL3081155 | 1.00 | CD81 (0.34) | CD81ALDH1A1CA2PPARG | |
| SCHEMBL6851328 | 0.92 | CD81 (0.38) | CD81ALDH1A1PPARG | |
| SCHEMBL6851323 | 0.92 | CD81 (0.38) | CD81ALDH1A1PPARG | |
| SCHEMBL15535508 | 0.90 | CD81 (0.39) | CD81PPARG | |
| SCHEMBL137136 | 0.88 | CD81 (0.38) | CD81ALDH1A1PPARG | |
| SCHEMBL621263 | 0.88 | CD81 (0.38) | CD81ALDH1A1PPARG | |
| SCHEMBL8928149 | 0.86 | ALDH1A1 (0.39) | CD81ALDH1A1CA2 | |
| SCHEMBL8928144 | 0.86 | ALDH1A1 (0.39) | CD81ALDH1A1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 450 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260069172-A1 | DIFFUSION LAYER FOR AN ENZYMATIC IN-VIVO SENSOR | ROCHE DIABETES CARE INC (US) | 2026-03-12 | — | — | US | claimed |
| EP-3934705-B1 | INTRAOCULAR LENS COMPOSITIONS | TELEON HOLDING B V (NL) | 2025-11-19 | — | — | EP | claimed |
| EP-4338702-A1 | NON-REACTIVE TRANSFER RAILS | VOCO GmbH (DE) | 2024-03-20 | — | — | EP | claimed |
| WO-2023161081-A1 | WATERBORNE BIODEGRADABLE POLYMER COMPOSITION | ORGANIK KIMYA SANAYI VE TIC. A.S. (TR) | 2023-08-31 | — | — | WO | claimed |
| EP-4093781-A1 | METHOD FOR PRODUCING REMOVABLE PRESSURE-SENSITIVE ADHESIVES (PSAS) USING BIO-BASED STARTING MATERIALS | The University of the Basque Country (ES) | 2022-11-30 | — | — | EP | claimed |
| EP-4045546-A1 | METHOD FOR PRODUCING A REMOVABLE PRESSURE-SENSITIVE ADHESIVE (PSA) AND PRESSURE-SENSITIVE ADHESIVE THUS PRODUCED | The University of the Basque Country (ES) | 2022-08-24 | — | — | EP | claimed |
| US-20220235231-A1 | METHOD FOR PROVIDING COATING SYSTEMS WITH CORROSION-PROTECTIVE PROPERTIES | FUNDACIÓN CIDETEC (ES) | 2022-07-28 | — | — | US | claimed |
| EP-3787509-B1 | IMPROVED DIFFUSION LAYER FOR AN ENZYMATIC IN-VIVO SENSOR | HOFFMANN LA ROCHE (CH) | 2022-06-22 | — | — | EP | claimed |
| EP-3980476-A1 | METHOD FOR PRODUCING A POLYMERIC COMPOSITION AND POLYMERIC COMPOSITION THUS PRODUCED AS WELL AS APPLICATIONS THEREOF, ESPECIALLY AS OR IN PRESSURE-SENSITIVE ADHESIVES | University of the Basque Country (ES) | 2022-04-13 | — | — | EP | claimed |
| WO-2021249660-A1 | METHOD FOR PRODUCING REMOVABLE PRESSURE-SENSITIVE ADHESIVES (PSAS) USING BIO-BASED STARTING MATERIALS | THE UNIVERSITY OF THE BASQUE COUNTRY (ES) | 2021-12-16 | — | — | WO | claimed |
| WO-2018187515-A1 | PEPTIDE-BASED VACCINES, METHODS OF MANUFACTURING, AND USES THEREOF FOR INDUCING AN IMMUNE RESPONSE | AVIDEA TECHNOLOGIES, INC. (US) | 2018-10-11 | — | — | WO | claimed |
| US-9522114-B1 | Enhanced targeted drug delivery system via chitosan hydrogel and chlorotoxin | UNIVERSITY OF SOUTH FLORIDA (US) | 2016-12-20 | — | — | US | claimed |
| EP-2735451-B1 | Polymer blend and article of manufacture such as a tire comprising such a blend | GOODYEAR TIRE & RUBBER (US) | 2015-11-04 | — | — | EP | claimed |
| EP-2852631-A1 | METHOD FOR PRODUCING A NANOCOMPOSITE DISPERSION COMPRISING COMPOSITE PARTICLES OF INORGANIC NANOPARTICLES AND ORGANIC POLYMERS | Akzo Nobel Coatings International B.V. (NL) | 2015-04-01 | — | — | EP | claimed |
| WO-2014005753-A1 | METHOD FOR PRODUCING A NANOCOMPOSITE DISPERSION COMPRISING COMPOSITE PARTICLES|OF INORGANIC NANOPARTICLES AND ORGANIC POLYMERS | AKZO NOBEL COATINGS INTERNATIONAL B.V. (NL) | 2014-01-09 | — | — | WO | claimed |
| US-20130112623-A1 | COMPOSITE MATERIAL | JACOBS UNIVERSITY BREMEN GGMBH (DE) | 2013-05-09 | — | — | US | claimed |
| EP-0826751-B1 | Aqueous dispersions containing graft copolymers as the dispersant | DU PONT (US) | 2004-04-28 | — | — | EP | claimed |
| EP-0851014-B1 | Ink jet inks containing hydrosols as polymer additives | DU PONT (US) | 2002-07-03 | — | — | EP | claimed |
| EP-0779305-B1 | Macromonomers with high acid content and their method of preparation | DU PONT (US) | 1999-03-03 | — | — | EP | claimed |
| EP-0080680-B1 | REFERENCE ELECTRODE CATHETER | Sentron v.o.f. (NL) | 1988-03-30 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260069172-A1 | DIFFUSION LAYER FOR AN ENZYMATIC IN-VIVO SENSOR | LDHA, LDHB, BTD | CD81 1727/4885ALDH1A1 253/4885CA2 121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.